Larry Robbins, founder of healthcare-focused Glenview, has established a large position in CVS and owns about 1% of its outstanding shares, the Journal reported. Robbins is expected to meet with Chief ...
Repare Therapeutics said it received encouraging early phase 1 data for its camonsertib inhibitor combined with palliative radiation for the treatment of metastatic tumors harboring an ...
CVS Health Corporation (NYSE: CVS) has caught the attention of the investment community today with its bullish price action. The company’s shares have moved 4.33% on the day to $61.57. CVS Health ...
Glenview Capital Management plans to meet Monday with CVS Health Corp. to propose ways for the health-care company to improve its operations, auguring a potential activist push by the hedge fund, the ...